Log in to save to my catalogue

Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesu...

Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5ed1692567c2416bb8a14de5de061787

Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesunate, France, 2011–2013

About this item

Full title

Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesunate, France, 2011–2013

Publisher

United States: U.S. National Center for Infectious Diseases

Journal title

Emerging infectious diseases, 2015-05, Vol.21 (5), p.804-812

Language

English

Formats

Publication information

Publisher

United States: U.S. National Center for Infectious Diseases

More information

Scope and Contents

Contents

Artesunate is the most effective treatment for severe malaria. However, delayed-onset hemolytic anemia has been observed in ≈20% of travelers who receive artesunate, ≈60% of whom require transfusion. This finding could discourage physicians from using artesunate. We prospectively evaluated a cohort of 123 patients in France who had severe imported...

Alternative Titles

Full title

Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesunate, France, 2011–2013

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5ed1692567c2416bb8a14de5de061787

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5ed1692567c2416bb8a14de5de061787

Other Identifiers

ISSN

1080-6040

E-ISSN

1080-6059

DOI

10.3201/eid2105.141171

How to access this item